news
Transfection technologies market to value $1.5 billion by 2026
Growth in the global transfection technologies market will be driven by emerging methods and the increasing prevalence of chronic diseases over the next five years.
List view / Grid view
Promega
article
Practical Workshop – Biochemical Assays for Screening
21 February 2013 | By Sheraz Gul, Head of Biology at European ScreeningPort, Hamburg, Germany
Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of universities worldwide that now host infrastructure such as compound libraries and automated screening centres[1-3]. An archetypal small molecule drug discovery project will aim to identify…
news
Tecan and Promega offer variable volume DNA isolation
15 November 2012 | By kdm communications limited
Tecan and Promega have developed a turnkey workstation for fully automated extraction of gDNA from whole blood samples...
